Feb 09, 2021

Investigational combo to be studied in hospitalized Covid patients The National Institutes of Health (NIH) announced that it has begun recruiting for a sub-study to assess AstraZeneca’s investigati...

Feb 09, 2021

MONDAY, Feb. 8, 2021 (HealthDay News) -- Online COVID-19 vaccine scams are becoming more widespread, security experts warn. In the last six weeks, there has been a sharp rise in the number of COVID-1...

Feb 09, 2021

MONDAY, Feb. 8, 2021 (HealthDay News) -- Among patients who suffer a cardiac arrest either in or out of hospital, those who are infected with COVID-19 are more likely to die than those who are not inf...

Feb 08, 2021

Can’t see the audio player? Click here to listen on SoundCloud. Nearly a year into the pandemic, many public schools are still closed to in-person instruction. Bu...

Feb 08, 2021

This story also ran on NPR. It can be republished for free. Counting the dead is one of the first, somber steps in reckoning with an event of enormous tragic scope, be it war, a ...

Feb 08, 2021

Covid-19’s fierce winter resurgence in California is notable not only for the explosion in overall cases and deaths in the state’s sprawling urban centers. This latest surge spilled across...

Feb 08, 2021

Modeling study considered testing strategies by community spread In communities where Covid-19 is spreading rapidly, weekly population-wide testing coupled with a two-week isolation period for thos...

Feb 08, 2021

Submission based on data from phase III ENSEMBLE trial Johnson & Johnson announced that it has issued an Emergency Use Authorization (EUA) application to the FDA for its single-dose Covid-19 va...

Feb 07, 2021

GRAND JUNCTION, Colo. — On a sunny Saturday in January, Ruth Hatfield was sitting with a friend’s dog on a sidewalk bench in downtown Grand Junction. Back home in Snowmass Village, 120 miles a...

Feb 07, 2021

Use Our Content It can be republished for free. President Joe Biden and a group of Republicans agreed this week on how much Congress should spend on vaccine distribution, covid-19 ...

Feb 05, 2021

THURSDAY, Feb. 4, 2021 (HealthDay News) -- Persons living with HIV who are diagnosed with COVID-19 are more likely to require hospitalization and to die, according to a study published online Feb. 3 i...

Feb 05, 2021

THURSDAY, Feb. 4, 2021 (HealthDay News) -- A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), has 91.6 percent efficacy against COVID-19, according to a study publis...

Feb 05, 2021

  This story also ran on PolitiFact. It can be republished for free. April 30 will mark the end of the first 100 days of President Joe Biden’s tenure. That’s a benchmark presidents often se...

Feb 05, 2021

NFID survey underscores need to address disparities and increase vaccine education Results from a survey commissioned by the National Foundation for Infectious Diseases (NFID) revealed very low con...

Feb 04, 2021

Four weeks after San Diego pediatric nurse Jennifer Minhas fell ill with covid-19 last March, her cough and fever had resolved, but new symptoms had emerged: chest pain, an elevated heart rate and cru...

Feb 04, 2021

The development of a COVID vaccine is one of the most closely watched human experiments in modern medical history. I’ve been thinking how this has played out. What were the broader forces that allow...

Feb 04, 2021

Roughly one-third of Americans say they will decline a COVID-19 vaccine, according to research published in Social Science & Medicine. Researchers assessed vaccine intention among 5,009 US adults ...

Feb 04, 2021

Delaying second doses could also free up scarce supply A modeling study suggests a greater population-level benefit for a single-dose Covid-19 vaccination strategy compared to the current 2-dose stra...

Feb 04, 2021

A boost in manufacturing should enable Germany’s BioNTech to produce 2 billion doses of its COVID-19 vaccine this year, the company says. With three manufacturing sites in the United States and thre...

Feb 04, 2021

More than 2 million in Russia have received the vaccine Peer-reviewed, interim phase III data from a trial of a Covid-19 vaccine developed in Russia showed an overall efficacy of 91.6%, with protec...